Annex

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance 'tylvalosin' is replaced by the following:

Pharmacologically active substance	Marker residue	Animal species	MRL	Target tissues	Other provisions (according to Article 14(7) of Regulation (EC) No 470/2009)	Therapeutic classification
‘Tylvalosin	Tylvalosin	Porcine	50 μg/kg 50 μg/kg 50 μg/kg 50 μg/kg	Muscle Skin and fat Liver Kidney	NO ENTRY	Anti-infectious agents/Antibiotics’
		Poultry	200 μg/kg	Eggs
	Sum of Tylvalosin and 3-0-acetyltylosin	Poultry	50 μg/kg 50 μg/kg	Skin and fat Liver